MitoRx Therapeutics

Series-A
mitorxtherapeutics.com Biotech & Healthcare
Total Funding $5.1M
Latest Round Undisclosed Series-A
Last Announced Nov 17, 2025
Investors Undisclosed
Decision Makers 4 Verified

About MitoRx Therapeutics

MitoRx is developing new treatments to restore healthy mitochondrial metabolism in patients living with high-risk obesity.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website mitorxtherapeutics.com
Domain Registered Date Aug 20, 2020

Social & Network Presence

X / Twitter Profile @MitoRxTheraLtd (143 followers) Created on Nov 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Series-A announced

    fundraisingfox.com

  2. Capital Raise

    Raised $5,070,000 · Seed

    startupintros.com

  3. Milestone

    X account created (@MitoRxTheraLtd)

    143 followers

  4. Milestone

    Website domain registered

    mitorxtherapeutics.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for MitoRx Therapeutics.

Funding History

2 Rounds
Series-A · Nov 17, 2025
Seed · Dec 18, 2023

Founders & Leadership

2

Jon Rees

Co-founder & Chief Executive Officer

Work email & phone locked Unlock →

Norman Law

Co-founder, Chief Technology Officer & Head of Intellectual Property

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts